Robert Ang insider trades

Open-market stock purchases and sales by Robert Ang, PRESIDENT AND CEO at Vor Biopharma Inc, from SEC Form 4 filings since Feb 27, 2019.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • VOR Vor Biopharma Inc: other filings, last May 6, 2025
  • NTGN Neon Therapeutics, Inc: other filings, last Feb 27, 2019

Get free alerts when Robert Ang files a new trade →